Treatment Options for Still's Disease
Begin – are you treating “systemic” or “articular” (arthritis) Still’s disease? Most Still’s patients…
View Resource
Sleep Apnea Smart Watches (10.13.2023)
Dr. Jack Cush reviews the news, journal reports and regulatory approvals from this past…
View Resource
Pharmacologic Efficacy in Still's Disease
A systematic review of the effectiveness and safety of pharmacological treatments for adult-onset Still’s…
View Resource
When to Stop Biologics in Systemic JIA?
Systemic onset juvenile idiopathic arthritis (sJIA) is a dramatic onset inflammatory condition marked by…
View Resource
Undifferentiated Autoinflammatory Syndrome Called VEXAS
Saturday’s session on autoinflammatory syndromes featured Dr. Dan Kastner addressing – The Adult with…
View Resource
The Still’s Continua
The concept of a “Still’s disease continuum” that encompasses both sJIA and AOSD is…
View Resource
Do biologics help taper steroids in Adult Still’s Disease?
Adult Still’s Disease is labeled as a rare disease as the prevalence of the…
View Resource
Anakinra Effective in Systemic JIA, Irrespective of HLA-DRB1 and IL1RN Variants
A prospective study of first line use anakinra in systemic juvenile idiopathic arthritis (sJIA) proved…
View Resource
Cutoffs for Systemic Juvenile Arthritis Disease Activity Score
An international cohort of children with systemic Juvenile idiopathic arthritis (Still’s disease) validated the…
View Resource
Risks associated with mortality in VEXAS
Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS) took the centre stage when it…
View Resource